Skip to main content
Equibles
INNV logo

INNV · InnovAge Holding Corp. · Earnings Call Transcripts & Audio

Track INNV — free

Use INNV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INNV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.80 -0.18 (-2.00%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$1.23B
Shares
136.45M
Volume · Sep 30 807.59K Avg daily vol (3M) 420.03K

InnovAge Holding Corp. Earnings Call Transcripts

Quarterly earnings calls for InnovAge Holding Corp. (INNV), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼1.1% $171.22M −$13.07M '23 Q1 22-11-08 ▼4.5% $167.46M −$9.79M '23 Q2 23-02-07 ▼2.7% $172.54M −$6.63M '23 Q3 23-05-09 ▲2.3% $176.87M −$11.18M '23 Q4 23-09-12 ▲6.6% $182.49M −$10.30M '24 Q1 23-11-07 ▲12.8% $188.90M −$3.45M '24 Q2 24-02-06 ▲11.9% $193.07M −$5.89M '24 Q3 24-05-07 ▲12.7% $199.40M −$1.70M '24 Q4 24-09-10 ▲12.4% $205.14M −$4.93M '25 Q1 24-11-05 ▲10.6% $209.00M −$13.22M '25 Q2 25-02-04 ▲13% $218.14M −$11.38M '25 Q3 25-05-06 ▲11% $221.42M −$785,000 '25 Q4 25-09-09 ▲15.1% $236.10M $8.02M '26 Q1 25-11-04 ▲14.7% $239.71M $10.62M '26 Q2 26-02-03 ▲15.5% $251.94M −$29.46M '26 Q3 26-05-05 LATEST ▲18.3% $261.95M $8.29M '26 Q4 26-09-08
Conference
Investor event
2026-09-09
InnovAge Holding Corp. (INNV) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2026-09-08
InnovAge Holding Corp. (INNV) Q4 2026 Earnings Call Transcript
Confident tone Rate environment and state rate setting Fiscal 2027 guidance and census outlook PACE policy environment and program adjacencies
Revenue
$261.95M*
▲ 18.3% YoY
Gross margin
23.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-05-05
InnovAge Holding Corp. (INNV) Q3 2026 Earnings Call Transcript
Confident tone Quality and participant outcomes Raised fiscal 2026 guidance Quarterly financial performance
Revenue
$251.94M
▲ 15.5% YoY
Diluted EPS
$-0.22
Gross margin
24.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-02-03
InnovAge Holding Corp. (INNV) Q2 2026 Earnings Call Transcript
Confident tone Participant experience and retention Medicaid rate environment Medicare Advantage and PACE rate risk
Revenue
$239.71M
▲ 14.7% YoY
Diluted EPS
$0.08
Gross margin
22.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-11-04
InnovAge Holding Corp. (INNV) Q1 2026 Earnings Call Transcript
Confident tone Financial performance and growth PACE model resilience vs. broader value-based care Pharmacy in-sourcing and cost structure
Revenue
$236.10M
▲ 15.1% YoY
Diluted EPS
$0.06
Gross margin
21.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-09-09
InnovAge Holding Corp. (INNV) Q4 2025 Earnings Call Transcript
Confident tone FY26 Guidance FY25 Results and Execution Medicaid Redeterminations and Enrollment
Revenue
$221.42M*
▲ 11% YoY
Gross margin
18.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-05-06
InnovAge Holding Corp. (INNV) Q3 2025 Earnings Call Transcript
Positive tone Census Growth and Participant Base Financial Performance and Reaffirmed Guidance PACE Advocacy and Policy Engagement
Revenue
$218.14M
▲ 13% YoY
Diluted EPS
$-0.08
Gross margin
18.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-02-04
InnovAge Holding Corp. (INNV) Q2 2025 Earnings Call Transcript
Positive tone Clinical and Operational Value Initiatives Pharmacy Insourcing Strategy De Novo and Acquired Centers
Revenue
$209.00M
▲ 10.6% YoY
Diluted EPS
$-0.10
Gross margin
17.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-11-05
InnovAge Holding Corp. (INNV) Q1 2025 Earnings Call Transcript
Revenue
$205.14M
▲ 12.4% YoY
Diluted EPS
$-0.04
Gross margin
16.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-09-10
InnovAge Holding Corp. (INNV) Q4 2024 Earnings Call Transcript
Positive tone Fiscal 2024 financial results De novo center ramp Fiscal 2025 guidance
Revenue
$199.40M*
▲ 12.7% YoY
Gross margin
18.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-05-07
InnovAge Holding Corp. (INNV) Q3 2024 Earnings Call Transcript
Positive tone PACE demand and enrollment growth De novo center expansion Financial guidance and outlook
Revenue
$193.07M
▲ 11.9% YoY
Diluted EPS
$-0.04
Gross margin
17.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-02-06
InnovAge Holding Corp. (INNV) Q2 2024 Earnings Call Transcript
Positive tone Seasonality and Guidance Uncertainty Geographic Expansion and Acquisitions Enrollment and Census Growth
Revenue
$188.90M
▲ 12.8% YoY
Diluted EPS
$-0.03
Gross margin
17.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-11-07
InnovAge Holding Corp. (INNV) Q1 2024 Earnings Call Transcript
Revenue
$182.49M
▲ 6.6% YoY
Diluted EPS
$-0.08
Gross margin
15.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-09-12
InnovAge Holding Corp. (INNV) Q4 2023 Earnings Call Transcript
Revenue
$176.87M*
▲ 2.3% YoY
Gross margin
16.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-05-09
InnovAge Holding Corp. (INNV) Q3 2023 Earnings Call Transcript
Revenue
$172.54M
▼ 2.7% YoY
Diluted EPS
$-0.05
Gross margin
16.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-02-07
InnovAge Holding Corp. (INNV) Q2 2023 Earnings Call Transcript
Revenue
$167.46M
▼ 4.5% YoY
Diluted EPS
$-0.07
▼ 800% YoY
Gross margin
13.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-11-08
InnovAge Holding Corp. (INNV) Q1 2023 Earnings Call Transcript
Revenue
$171.22M
▼ 1.1% YoY
Diluted EPS
$-0.10
▼ 266.7% YoY
Gross margin
12.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-09-13
InnovAge Holding Corp. (INNV) Q4 2022 Earnings Call Transcript
Revenue
$172.86M*
▲ 0.7% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-05-10
InnovAge Holding Corp. (INNV) Q3 2022 Earnings Call Transcript
Revenue
$177.36M
▲ 13.5% YoY
Diluted EPS
$-0.02
Gross margin
15.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-02-09
InnovAge Holding Corp. (INNV) Q2 2022 Earnings Call Transcript
Revenue
$175.35M
▲ 11.5% YoY
Diluted EPS
$0.01
▼ 87.5% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-11-09
InnovAge Holding Corp. (INNV) Q1 2022 Earnings Call Transcript
Revenue
$173.07M
▲ 13.4% YoY
Diluted EPS
$0.06
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-09-21
InnovAge Holding Corp. (INNV) Q4 2021 Earnings Call Transcript
Revenue
$171.62M*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-05-10
InnovAge Holding Corp. (INNV) Q3 2021 Earnings Call Transcript
Revenue
$156.31M
▲ 8% YoY
Diluted EPS
$-0.09
▼ 250% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 1834376 CUSIP 45784A104 13F (30d) 2 filings 2 filers Visit website Investor relations